As reported by The Cambridge Network, the leading technology design and development company, Cambridge Consultants have today released findings of a study which set out to investigate the impact of medical device usability on user acceptance.
The study concluded that pharmaceutical companies could boost their market share by shifting their emphasis to improve the user experience. Further findings of the study included:
- – Patients will may for ease-of-use – 77% of respondents stated that they would be willing to pay a premium for more user-friendly devices.
- – Patients now have more choice than ever – 75% of patients reported that their doctor gave them a choice of which medical device to chose – 28% took their doctors recommendation – 21% stated that they did their own research when choosing a new device
- – Lifestyle factors was the biggest reason for switching devices.
- – Doctors and healthcare providers surveyed noted that better devices resulted in better patient compliance
Speaking of the findings, Melanie Turieo, Human Factors Team Leader at Cambridge Consultants stated, “The findings challenge traditional medical device industry conceptions about compliance and the patient experience. The industry has been good at maximizing drug efficacy but patient experience factors have not really been a primary focus. Only now are we seeing the patient experience take centre stage.
Drug makers need to realize that if you consider the patient’s broader needs throughout the development process—from conception, to design, development and commercialization—you are likely to have a more successful and effective product, resulting in improved compliance and therefore improved patient outcomes.”